Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
21.08
+0.42 (2.03%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,385 | 4,767 | 4,115 | 3,300 | 2,871 | 3,120 | |
Market Cap Growth | 23.74% | 15.85% | 24.69% | 14.93% | -7.95% | -14.70% |
Enterprise Value | 7,772 | 6,966 | 6,320 | 5,531 | 5,083 | 3,873 |
Last Close Price | 21.08 | 18.94 | 17.32 | 14.27 | 12.43 | 13.54 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 80.60 | 29.59 | 32.07 | 237.83 | - | - |
PS Ratio | 6.23 | 6.52 | 6.18 | 5.39 | 4.89 | 5.65 |
PB Ratio | 1.96 | 1.69 | 1.50 | 1.18 | 0.94 | -8.80 |
P/TBV Ratio | 1.98 | 1.68 | 1.51 | 1.20 | 0.95 | - |
P/FCF Ratio | - | - | 34.46 | 24.06 | 16.99 | 14.56 |
P/OCF Ratio | 14.49 | 13.67 | 13.25 | 10.98 | 9.09 | 8.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.00 | 9.53 | 9.49 | 9.03 | 8.65 | 7.01 |
EV/EBITDA Ratio | 23.75 | 17.42 | 17.04 | 15.57 | 17.47 | 10.67 |
EV/EBIT Ratio | 66.00 | 32.71 | 31.38 | 32.14 | 49.30 | 21.05 |
EV/FCF Ratio | - | - | 52.93 | 40.32 | 30.07 | 18.07 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.82 | 0.80 | 0.83 | 0.81 | 0.74 | -2.14 |
Debt / EBITDA Ratio | 6.93 | 5.67 | 6.11 | 6.40 | 7.77 | 2.09 |
Debt / FCF Ratio | - | - | 18.98 | 16.56 | 13.37 | 3.53 |
Net Debt / Equity Ratio | 0.74 | 0.78 | 0.80 | 0.80 | 0.72 | -2.12 |
Net Debt / EBITDA Ratio | 6.22 | 5.49 | 5.94 | 6.28 | 7.60 | 2.08 |
Net Debt / FCF Ratio | -5.56 | -15.06 | 18.47 | 16.26 | 13.08 | 3.51 |
Asset Turnover | 0.15 | 0.14 | 0.12 | 0.11 | 0.19 | 1.15 |
Quick Ratio | 2.01 | 0.60 | 0.51 | 0.30 | 0.35 | 0.24 |
Current Ratio | 3.21 | 1.59 | 1.68 | 1.32 | 1.42 | 0.57 |
Return on Equity (ROE) | 2.34% | 5.59% | 4.57% | 0.47% | -5.74% | 32.91% |
Return on Assets (ROA) | 2.07% | 3.90% | 3.74% | 2.70% | 3.37% | 39.09% |
Return on Invested Capital (ROIC) | 2.35% | 4.22% | 4.00% | 2.92% | 3.68% | 42.47% |
Return on Capital Employed (ROCE) | 2.19% | 4.03% | 3.86% | 3.17% | 3.42% | 41.78% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.22% | 3.38% | 3.12% | 0.42% | - | - |
FCF Yield | - | - | 2.90% | 4.16% | 5.89% | 6.87% |
Dividend Yield | 5.69% | 6.33% | 6.93% | 8.41% | 9.65% | 8.86% |
Payout Ratio | 458.84% | 186.04% | 221.09% | 2016.92% | -357.14% | -232.15% |
Buyback Yield / Dilution | -5.18% | -3.58% | -1.40% | -0.80% | -5.42% | -5.70% |
Total Shareholder Return | 0.51% | 2.75% | 5.53% | 7.61% | 4.23% | 3.16% |